Chronic Pain Management for Seniors

Acetaminophen (Tylenol) is the safest analgesic for chronic musculoskeletal pain in seniors, recommended as first-line by the American Geriatrics Society. At appropriate doses — a maximum of 3,000mg per day in seniors (reduced from the adult maximum of 4,000mg) — acetaminophen is safe for most seniors: it does not cause GI bleeding, does not impair kidney function, does not cause fluid retention, and does not worsen heart failure or blood pressure. The dose should be further reduced to 2,000mg per day in seniors who drink alcohol regularly or have liver disease. The most important caution with acetaminophen is hidden sources — many OTC combination products (NyQuil, DayQuil, many PM sleep aids, opioid combination pills like Percocet and Vicodin) contain acetaminophen. Total intake from all sources must stay under 3,000mg/day. For localized joint pain, topical diclofenac gel (Voltaren Arthritis 1% — now available OTC) provides NSAID-level pain relief with less than 5% of the systemic absorption of oral NSAIDs — effectively eliminating the GI bleeding, renal, and cardiovascular risks that make oral NSAIDs dangerous for seniors.

Oral NSAIDs — including ibuprofen (Advil, Motrin), naproxen (Aleve), diclofenac (Voltaren oral), and even the 'safer' COX-2 inhibitor celecoxib (Celebrex) — are on the 2023 Beers Criteria AVOID list for seniors due to serious risks that increase significantly with age. GI bleeding: NSAIDs inhibit prostaglandins that protect the stomach lining. The risk of GI ulcer, bleeding, and perforation is 3–5 times higher in adults over 65 compared to younger adults. Adding aspirin or steroids to NSAIDs multiplies this risk further. Renal impairment: NSAIDs reduce renal blood flow by constricting afferent arterioles. In seniors — who commonly have some degree of reduced GFR, CKD, or are on ACE inhibitors and diuretics — even a few days of NSAID use can cause acute kidney injury. Cardiovascular risk: NSAIDs cause fluid retention, raise blood pressure, and worsen heart failure through sodium and water retention — effects that are especially dangerous in seniors with established cardiac disease. The safest alternative for localized joint pain is topical diclofenac 1% gel (Voltaren Arthritis Pain — now OTC). It delivers equivalent joint pain relief with less than 5% systemic absorption, virtually eliminating the GI, renal, and cardiovascular risks. For widespread pain, acetaminophen, duloxetine, or physical therapy are the preferred options.

No — all commonly prescribed skeletal muscle relaxants are on the 2023 Beers Criteria AVOID list for seniors. This includes cyclobenzaprine (Flexeril), methocarbamol (Robaxin), carisoprodol (Soma), baclofen (at higher doses), and orphenadrine. The risks in seniors: anticholinergic effects (cyclobenzaprine, orphenadrine) — confusion, urinary retention, constipation, dry mouth, blurred vision. CNS depression — sedation and dizziness cause falls, which in a senior can mean a hip fracture and 25–35% one-year mortality. Carisoprodol (Soma) metabolizes to meprobamate (a barbiturate) and is a Schedule IV controlled substance with dependence potential. The evidence for benefit is weak: muscle relaxants show modest short-term effect for acute muscle spasm in younger adults, but chronic use for chronic pain shows minimal benefit. Safer alternatives for acute spasm in seniors: heat therapy (moist heat to the affected area), topical diclofenac or lidocaine patch, TENS therapy, and a physical therapy referral for movement-based treatment of the underlying musculoskeletal dysfunction.

The CDC 2022 Clinical Practice Guideline on opioid prescribing recommends that opioids be considered for pain when it is severe, functionally impairing, and non-opioid therapies have been inadequate. In seniors, this commonly applies to cancer pain, severe osteoarthritis awaiting or ineligible for surgery, severe vertebral compression fracture pain, or end-of-life pain management. When opioids are used in seniors: always start at the lowest available dose (oxycodone IR 2.5mg, hydrocodone IR 2.5mg, morphine IR 2.5–5mg) and titrate slowly ('start low, go slow'). Use immediate-release formulations only in opioid-naive seniors — avoid extended-release/long-acting opioids until an appropriate dose has been established. Always prescribe a bowel regimen simultaneously — opioid-induced constipation affects virtually all patients and does not resolve with tolerance. A stimulant laxative (senna) is required; docusate (Colace) alone is insufficient. Avoid meperidine (Demerol) in seniors at all times — it accumulates a neurotoxic metabolite (normeperidine) that causes seizures. Monitor for sedation, falls, and cognitive changes. Reassess benefit and risk at every visit. Avoid combining opioids with benzodiazepines — this combination is associated with respiratory depression and death.

Multiple non-pharmacological treatments have Level I evidence for chronic pain in seniors and should be used as first-line or alongside medication. Exercise is the single most evidence-based intervention — aerobic exercise (walking, aquatic therapy, cycling) and strength training reduce pain scores by 30–50% in osteoarthritis trials, improve function, reduce fall risk, and improve mood. Physical therapy addresses the biomechanical sources of pain through guided exercise, manual therapy, and functional training — Medicare Part B covers PT with physician referral. Cognitive Behavioral Therapy for Pain (CBT-P) targets the pain catastrophizing, fear-avoidance, and depression that amplify chronic pain — studies show it reduces pain intensity, improves function, and reduces analgesic use. Acupuncture has Level I Cochrane evidence for OA, chronic back pain, neck pain, and headache — Medicare now covers up to 20 sessions for chronic low back pain, and many Medicare Advantage plans cover broader acupuncture benefits. TENS (transcutaneous electrical nerve stimulation) provides moderate evidence for knee OA and back pain without systemic side effects — an important option for seniors who cannot tolerate medication side effects. Heat therapy (moist heat pads, paraffin wax baths for hand OA) is self-administered, inexpensive, and effective for musculoskeletal pain. Weight management reduces knee OA pain — each pound of weight lost reduces knee joint force by four pounds.

Pain is significantly undertreated in seniors with dementia because verbal self-report — the standard pain assessment method — is unreliable in moderate-to-advanced cognitive impairment. Seniors with dementia often cannot reliably rate pain on a 0–10 scale, remember whether pain occurred, or describe its character. Behavioral observation scales are used instead. The PAINAD scale (Pain Assessment in Advanced Dementia) assesses five behavioral domains: breathing pattern, negative vocalization (moaning, crying), facial expression (grimacing, frowning), body language (guarding, rigid posture), and consolability — scored 0–10. The Abbey Pain Scale is validated specifically for end-stage dementia. In the absence of a formal scale, behavioral clues that should prompt a pain assessment include: unexplained restlessness or agitation, grimacing or wincing during movement (dressing, transfers, repositioning), resistance to care that was previously accepted, decreased appetite, rocking, guarding of a body part, social withdrawal, or new aggression. A practical diagnostic approach: if a senior with dementia shows behavioral changes, a trial of scheduled acetaminophen (500–650mg every 6 hours for 3–5 days) can both treat potential pain and confirm its presence if behavior improves. This avoids the risks of PRN-only prescribing in patients who cannot request pain medication.

Acetaminophen toxicity from unintentional overdose is a serious and underrecognized risk in seniors. The problem: acetaminophen is present in hundreds of OTC and prescription combination products under trade names that give no indication of their acetaminophen content. Common sources of hidden acetaminophen include: cold/flu products (NyQuil, DayQuil, TheraFlu, Sudafed PE), PM sleep aids and pain relievers (Tylenol PM, Advil PM, ZzzQuil PM — all contain diphenhydramine PLUS acetaminophen), prescription opioid combinations (Percocet = oxycodone + acetaminophen; Vicodin = hydrocodone + acetaminophen; Norco; Lortab), and allergy/sinus medications. A senior who takes two regular-strength Tylenol tablets three times a day (1,950mg) and then takes Percocet 5/325 three times a day (975mg more acetaminophen) is at 2,925mg — barely under the senior limit. Adding a single dose of NyQuil at night (650mg) would push the total to 3,575mg — over the senior limit. The solution: when acetaminophen is the pain management plan, do a complete review of ALL medications (OTC, prescription, and supplements) for acetaminophen content. Check the Drug Facts label — acetaminophen is also listed as 'APAP' or 'paracetamol' on some labels. Keep a running total of daily acetaminophen from all sources and stay under 3,000mg/day for seniors.